FATE THERAPEUTICS INC
Total Trades
59
Buys
5
Sells
44
Largest Trade
$1M+
Insiders
12
Institutional Funds
112
Inst. Value
$1M+
Activist Filings
28
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| TAHL CINDY | See Remarks | SELL | $1K–$15K | 11K | $1.06 | Jan 12, 2026 |
| Valamehr Bahram | President and CEO | SELL | $1K–$15K | 5K | $1.07 | Jan 12, 2026 |
| Bressi Jerome Charles | See Remarks | SELL | $1K–$15K | 6K | $1.55 | Jan 13, 2025 |
| TAHL CINDY | See Remarks | SELL | $1K–$15K | 6K | $1.55 | Jan 13, 2025 |
| Valamehr Bahram | President and CEO | SELL | $1K–$15K | 9K | $1.54 | Jan 13, 2025 |
| Redmile Group, LLC | Director | SELL | $500K+ | 342K | $1.68 | Dec 27, 2024 |
| Redmile Group, LLC | Director | BUY | $500K+ | 398K | $1.68 | Dec 27, 2024 |
| Dulac Edward J III | CFO | SELL | $1K–$15K | 2K | $5.00 | Jan 30, 2024 |
| Dulac Edward J III | CFO | SELL | $15K–$50K | 5K | $3.66 | Jan 3, 2024 |
| Redmile Group, LLC | Director | BUY | $100K–$500K | 45K | $3.72 | Dec 29, 2023 |
| TAHL CINDY | General Counsel an… | SELL | $50K–$100K | 24K | $2.40 | Nov 13, 2023 |
| Dulac Edward J III | CFO | SELL | $1K–$15K | 5K | $2.80 | Aug 21, 2023 |
| Xu Yuan | Director | SELL | $1K–$15K | 632 | $3.71 | Aug 7, 2023 |
| Powl Brian T. | Chief Commercial O… | SELL | $15K–$50K | 4K | $4.87 | Jul 6, 2023 |
| Dulac Edward J III | CFO | SELL | $15K–$50K | 5K | $4.83 | Jul 6, 2023 |
| Xu Yuan | Director | SELL | $15K–$50K | 3K | $5.58 | Jun 15, 2023 |
| Redmile Group, LLC | Director | BUY | $1M+ | 277K | $6.17 | Apr 22, 2023 |
| Chu Yu-Waye | Chief Medical Offi… | SELL | $15K–$50K | 3K | $6.57 | Apr 19, 2023 |
| Redmile Group, LLC | Director | BUY | $100K–$500K | 26K | $6.00 | Apr 18, 2023 |
| Redmile Group, LLC | Director | SELL | $1M+ | 302K | $5.84 | Apr 18, 2023 |
| MENDLEIN JOHN | Director | BUY | $500K+ | 125K | $5.60 | Jan 13, 2023 |
| Wolchko J Scott | President and CEO | SELL | $100K–$500K | 46K | $5.24 | Jan 11, 2023 |
| Valamehr Bahram | Chief R&D Officer | SELL | $50K–$100K | 11K | $5.24 | Jan 11, 2023 |
| TAHL CINDY | General Counsel an… | SELL | $50K–$100K | 12K | $5.24 | Jan 11, 2023 |
| Plavsic Mark | Chief Technical Of… | SELL | $15K–$50K | 3K | $5.24 | Jan 11, 2023 |
| Dulac Edward J III | CFO | SELL | $15K–$50K | 7K | $5.24 | Jan 11, 2023 |
| Chu Yu-Waye | Chief Medical Offi… | SELL | $15K–$50K | 8K | $5.24 | Jan 11, 2023 |
| Dulac Edward J III | CFO | SELL | $100K–$500K | 5K | $29.81 | Aug 19, 2022 |
| Wolchko J Scott | President and CEO | SELL | $1M+ | 36K | $32.74 | Jul 25, 2022 |
| Wolchko J Scott | President and CEO | EXERCISE | $50K–$100K | 36K | $2.70 | Jul 25, 2022 |
| Valamehr Bahram | Chief R&D Officer | SELL | $500K+ | 17K | $30.23 | Jul 8, 2022 |
| Valamehr Bahram | Chief R&D Officer | EXERCISE | $15K–$50K | 17K | $2.73 | Jul 8, 2022 |
| Valamehr Bahram | Chief R&D Officer | SELL | $100K–$500K | 8K | $30.07 | Jul 7, 2022 |
| Valamehr Bahram | Chief R&D Officer | EXERCISE | $15K–$50K | 8K | $3.27 | Jul 7, 2022 |
| Plavsic Mark | Chief Technical Of… | SELL | $50K–$100K | 4K | $24.61 | Jul 6, 2022 |
| Agarwal Shefali | Director | SELL | $15K–$50K | 841 | $21.89 | Jun 8, 2022 |
| TAHL CINDY | General Counsel an… | EXERCISE | $100K–$500K | 25K | $6.55 | Jun 2, 2022 |
| TAHL CINDY | General Counsel an… | SELL | $500K+ | 25K | $22.96 | Jun 2, 2022 |
| Wolchko J Scott | President and CEO | SELL | $1M+ | 40K | $34.89 | Apr 25, 2022 |
| Wolchko J Scott | President and CEO | EXERCISE | $100K–$500K | 40K | $2.70 | Apr 25, 2022 |
| Chu Yu-Waye | Chief Medical Offi… | SELL | $100K–$500K | 4K | $35.37 | Apr 21, 2022 |
| TAHL CINDY | General Counsel an… | EXERCISE | $100K–$500K | 25K | $5.22 | Apr 4, 2022 |
| TAHL CINDY | General Counsel an… | SELL | $500K+ | 25K | $38.85 | Apr 4, 2022 |
| Valamehr Bahram | Chief R&D Officer | SELL | $500K+ | 25K | $31.07 | Mar 15, 2022 |
| Valamehr Bahram | Chief R&D Officer | EXERCISE | $50K–$100K | 25K | $2.73 | Mar 15, 2022 |
| MENDLEIN JOHN | Director | EXERCISE | $50K–$100K | 32K | $1.63 | Mar 11, 2022 |
| MENDLEIN JOHN | Director | SELL | $1M+ | 32K | $35.02 | Mar 11, 2022 |
| Wolchko J Scott | President and CEO | EXERCISE | $100K–$500K | 40K | $2.72 | Jan 24, 2022 |
| Wolchko J Scott | President and CEO | SELL | $1M+ | 40K | $39.66 | Jan 24, 2022 |
| Wolchko J Scott | President and CEO | SELL | $500K+ | 15K | $48.68 | Jan 13, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 112 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Redmile Group, LLC | 12.9M | $1M+ | SH |
| JOHNSON & JOHNSON | 3.4M | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 2.9M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 2.4M | $1M+ | SH |
| STATE STREET CORP | 2.3M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $1M+ | SH |
| Point72 Asset Management, L.P. | 1.5M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 1.5M | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 1.2M | $1M+ | SH |
| Monaco Asset Management SAM | 830K | $500K+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 785K | $500K+ | SH |
| Bruce & Co., Inc. | 729K | $500K+ | SH |
| JANE STREET GROUP, LLC | 695K | $500K+ | SH |
| BlackRock, Inc. | 424K | $100K–$500K | SH |
| Privium Fund Management B.V. | 369K | $100K–$500K | SH |
| Knott David M Jr | 365K | $100K–$500K | SH |
| GOLDMAN SACHS GROUP INC | 303K | $100K–$500K | SH |
| Man Group plc | 261K | $100K–$500K | SH |
| BARCLAYS PLC | 230K | $100K–$500K | SH |
| GSA CAPITAL PARTNERS LLP | 214K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Schonfeld Strategic Advisors LLC
SC 13G/A · Aug 14, 2025
0.8%
938K shares
SC 13G/A · Aug 14, 2025
2.0%
2.3M shares
SC 13G/A · Jul 29, 2025
7.6%
8.8M shares
SC 13D/A · Jul 3, 2025
14.9%
17.9M shares
Schonfeld Strategic Advisors LLC
SC 13G · May 15, 2025
6.8%
7.8M shares
SC 13G · May 9, 2025
7.4%
8.5M shares
SC 13G/A · Apr 24, 2025
6.9%
7.9M shares
SC 13D/A · Dec 27, 2024
14.9%
17.8M shares
Point72 Asset Management, L.P.
SC 13G/A · Nov 15, 2024
0.0%
0 shares
SC 13G/A · Nov 8, 2024
9.2%
10.5M shares
SC 13G/A · Oct 26, 2024
0.0%
0 shares
SC 13G/A · Oct 21, 2024
9.2%
10.5M shares
SC 13D/A · Mar 25, 2024
14.9%
17.6M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.4%
9.3M shares
SC 13G · Feb 12, 2024
6.3%
6.2M shares
Capital World Investors 95-1411037
SC 13G/A · Feb 9, 2024
0.0%
0 shares
Point72 Asset Management, L.P.
SC 13G · Jan 25, 2024
4.8%
4.7M shares
SC 13G/A · Jan 24, 2024
11.4%
11.2M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 22, 2024
1.9%
0 shares
SC 13D/A · Dec 28, 2023
14.9%
15.0M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Oct 10, 2023
2.3%
0 shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · May 10, 2023
14.2%
0 shares
SC 13D/A · Apr 19, 2023
14.9%
15.1M shares
SC 13G · Mar 22, 2023
1.7%
1.7M shares
The Vanguard Group - 23-1945930
SC 13G/A · Mar 10, 2023
10.1%
9.9M shares
Capital World Investors 95-1411037
SC 13G · Feb 13, 2023
5.8%
5.6M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Feb 3, 2023
6.1%
0 shares
SC 13G/A · Jan 6, 2023
10.0%
9.7M shares